Patents by Inventor Henry Friedman

Henry Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230290366
    Abstract: A method for dynamically controlling enhancement of an audio stream is provided, where the audio stream defines a sequence of audio segments over time. Each audio segment defines a waveform having a plurality of waveform attributes. For each audio segment of the sequence of audio segments, the method includes: (i) determining a set of waveform-attribute values of the audio segment's waveform attributes, (ii) computing a first distance between the determined set of waveform-attribute values and a first predefined set of waveform-attribute values representative of speech, and computing a second distance between the determined set of waveform-attribute values and a second predefined set of waveform-attribute values representative of music, (iii) using the computed first and second distances as a basis to classify the audio segment as primarily speech or rather primarily music, and (iv) controlling, based on the classifying, whether or not to enhance the audio segment for output.
    Type: Application
    Filed: March 10, 2022
    Publication date: September 14, 2023
    Inventors: David Henry Friedman, Alan Robert Bithell, Robert Caston Curtis
  • Patent number: 11586754
    Abstract: Applications of the privacy switch technology are shown for handling data breaches in database systems, thereby providing fundamental improvements to the security and utility of database technology.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: February 21, 2023
    Assignee: Safelishare, Inc.
    Inventors: Shamim A. Naqvi, Robert F. Raucci, John Henry Friedman
  • Publication number: 20210192066
    Abstract: Applications of the privacy switch technology are shown for handling data breaches in database systems, thereby providing fundamental improvements to the security and utility of database technology.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 24, 2021
    Inventors: Shamim A. Naqvi, Robert F. Raucci, John Henry Friedman
  • Publication number: 20210106633
    Abstract: Provided is a method of treating a tumor in an individual by neoadjuvant therapy, wherein the individual has not previously undergone treatment to effectively reduce tumor burden, the method comprising administering an oncolytic chimeric poliovirus construct, or an oncolytic chimeric poliovirus construct and an immune checkpoint inhibitor, followed by reduction of the tumor. The method may further comprise administration of immune checkpoint inhibitor or oncolytic chimeric poliovirus construct following reduction of tumor. Kits for performing the methods are also provided.
    Type: Application
    Filed: April 2, 2019
    Publication date: April 15, 2021
    Applicant: Duke University
    Inventors: Darell Bigner, Matthias Gromeier, Smita Nair, Henry Friedman, Annick Desjardins
  • Patent number: 10860735
    Abstract: Applications of the privacy switch technology are shown for handling data breaches in database systems, thereby providing fundamental improvements to the security and utility of database technology.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: December 8, 2020
    Assignee: SENSORIANT, INC.
    Inventors: Shamim A. Naqvi, Robert F. Raucci, John Henry Friedman
  • Publication number: 20180150647
    Abstract: Applications of the privacy switch technology are shown for handling data breaches in database systems, thereby providing fundamental improvements to the security and utility of database technology.
    Type: Application
    Filed: January 23, 2018
    Publication date: May 31, 2018
    Inventors: Shamim A. Naqvi, Robert F. Raucci, John Henry Friedman
  • Patent number: 4075222
    Abstract: There are disclosed novel 3-(5-nitro-2-imidazolyl)pyrazoles exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of cattle, swine, and poultry. The compounds are also active as growth promoters in chickens.
    Type: Grant
    Filed: May 6, 1976
    Date of Patent: February 21, 1978
    Assignee: Eli Lilly and Company
    Inventors: John Pomfret Verge, Martin Charles Neville, Henry Friedman
  • Patent number: 4029671
    Abstract: There are disclosed novel 3-[(5-nitro-2-imidazolyl)pyrazol-5-yl]oxamic acid derivatives and salts thereof, exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of cattle, swine, and poultry.
    Type: Grant
    Filed: March 22, 1976
    Date of Patent: June 14, 1977
    Assignee: Eli Lilly and Company
    Inventors: Henry Friedman, Emily J. Canada
  • Patent number: 4001230
    Abstract: There are disclosed novel 3-(5-nitroimidazol-2-yl)-pyrazolo[3,4-d]pyrimidine compounds exhibiting utility as antibacterial and antiprotozoal agents.
    Type: Grant
    Filed: January 31, 1975
    Date of Patent: January 4, 1977
    Assignee: Eli Lilly and Company
    Inventor: Henry Friedman
  • Patent number: 3980794
    Abstract: There are disclosed novel 3-(5-nitro-2-imidazolyl)-pyrazoles exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of cattle, swine, and poultry. The compounds are also active as growth promoters in chickens.
    Type: Grant
    Filed: March 14, 1975
    Date of Patent: September 14, 1976
    Assignee: Eli Lilly and Company
    Inventors: John Pomfret Verge, Martin Charles Neville, Henry Friedman
  • Patent number: 3947467
    Abstract: There are disclosed novel 3-(5-nitro-2-imidazolyl)-pyrazoles exhibiting utility as antibacterial, antiprotozoal, and antifungal agents, making the compounds useful particularly in veterinary medicine, especially in controlling bacterial and protozoal infections of poultry and swine. The compounds are also active as growth promoters in chickens.
    Type: Grant
    Filed: May 13, 1974
    Date of Patent: March 30, 1976
    Assignee: Eli Lilly and Company
    Inventors: John Pomfret Verge, Martin Charles Neville, Henry Friedman